Indian pharmaceutical company Intas Pharmaceuticals has been granted an injunction preventing a rival from marketing an anti-epilepsy drug it said infringed one of its trademarks.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Intas, Arinna, trademark, Delhi High Court, Valrope, Valprol